{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-292501","form_type":"8-K","ticker":"SGMO","cik":"0001001233","company_name":"SANGAMO THERAPEUTICS, INC","filed_at":"2026-07-01T20:01:16+00:00","discovered_at":"2026-07-01T20:02:00.374845+00:00","generated_at":"2026-07-01T20:03:05.397554+00:00","sec_items":["4.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Sangamo Therapeutics files Chapter 11; stock now trades on OTCID Basic under SGMOQ; auditor EY terminated","bullets":["Filed voluntary Chapter 11 petition (Case No. 26-10989) on June 24, 2026.","Common stock began trading on OTCID Basic Market under symbol SGMOQ on June 24, 2026.","Nasdaq delisting appeal pending; stock suspended from Nasdaq since May 5, 2026.","Audit committee terminated Ernst & Young as independent auditor on June 25, 2026.","No new auditor engaged; EY's reports included going-concern explanatory paragraph."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-292501","json":"https://secwatch.observer/filing/0001193125-26-292501.json","markdown":"https://secwatch.observer/filing/0001193125-26-292501.md","text":"https://secwatch.observer/filing/0001193125-26-292501.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001233/000119312526292501/0001193125-26-292501-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001233/000119312526292501/d113173d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-01T20:03:05.397554+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}